Published in World J Surg on June 01, 2012
Clinical decision-making tools for exam selection, reporting and dose tracking. Pediatr Radiol (2014) 0.81
Preoperative localization strategies for primary hyperparathyroidism: an economic analysis. Ann Surg Oncol (2012) 0.81
Risk of malignancy associated with head and neck CT in children: a systematic review. Otolaryngol Head Neck Surg (2014) 0.81
Clinical applications of dual-energy CT in head and neck imaging. Eur Arch Otorhinolaryngol (2014) 0.79
MR appearance of parathyroid adenomas at 3 T in patients with primary hyperparathyroidism: what radiologists need to know for pre-operative localization. Eur Radiol (2015) 0.76
Clinical efficacy of 2-phase versus 4-phase computed tomography for localization in primary hyperparathyroidism. Surgery (2016) 0.75
Use of PET tracers for parathyroid localization: a systematic review and meta-analysis. Langenbecks Arch Surg (2016) 0.75
Preoperative localization of hyperfunctioning parathyroid glands with 4D-CT. Eur Arch Otorhinolaryngol (2015) 0.75
Evaluation of the radiation dose exposure and associated cancer risks in patients having preoperative parathyroid localization. Ann R Coll Surg Engl (2017) 0.75
Is Unilateral Neck Surgery Feasible in Patients with Sporadic Primary Hyperparathyroidism and Double Negative Localisation? World J Surg (2017) 0.75
Detection of parathyroid adenomas using a monophasic dual-energy computed tomography acquisition: diagnostic performance and potential radiation dose reduction. Neuroradiology (2016) 0.75
Diagnostic value and clinical impact of complementary CT scan prior to surgery for non-localized primary hyperparathyroidism. Langenbecks Arch Surg (2015) 0.75
Cancer risks from medical radiation. Health Phys (2003) 2.32
Prospective evaluation of delayed technetium-99m sestamibi SPECT scintigraphy for preoperative localization of primary hyperparathyroidism. Surgery (2002) 2.18
Improved preoperative planning for directed parathyroidectomy with 4-dimensional computed tomography. Surgery (2006) 2.09
The superiority of minimally invasive parathyroidectomy based on 1650 consecutive patients with primary hyperparathyroidism. Ann Surg (2011) 1.71
99Tcm sestamibi--a new agent for parathyroid imaging. Nucl Med Commun (1989) 1.63
Comparison of SPECT/CT, SPECT, and planar imaging with single- and dual-phase (99m)Tc-sestamibi parathyroid scintigraphy. J Nucl Med (2007) 1.41
Factors contributing to negative parathyroid localization: an analysis of 1000 patients. Surgery (2008) 1.37
Imaging for primary hyperparathyroidism--an evidence-based analysis. Langenbecks Arch Surg (2009) 1.30
Long-term risks for thyroid cancer and other neoplasms after exposure to radiation. Nat Clin Pract Endocrinol Metab (2005) 1.19
Thyroid dose from common head and neck CT examinations in children: is there an excess risk for thyroid cancer induction? Eur Radiol (2006) 1.17
Parathyroid exploration in the reoperative neck: improved preoperative localization with 4D-computed tomography. J Am Coll Surg (2008) 1.05
4D parathyroid CT as the initial localization study for patients with de novo primary hyperparathyroidism. Ann Surg Oncol (2010) 1.00
Parathyroid imaging: how good is it and how should it be done? Semin Nucl Med (2006) 0.90
Single photon emission computed tomography (SPECT) should be routinely performed for the detection of parathyroid abnormalities utilizing technetium-99m sestamibi parathyroid scintigraphy. Clin Nucl Med (2009) 0.86
Parathyroid tumors. Curr Treat Options Oncol (2003) 0.78
Tc-99m-MIBI scintigraphy for detecting parathyroid adenoma and hyperplasia. Ann Nucl Med (1997) 0.78
K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension. Science (2011) 5.40
Managing incidental findings on abdominal CT: white paper of the ACR incidental findings committee. J Am Coll Radiol (2010) 4.15
Diagnostic CT scans: assessment of patient, physician, and radiologist awareness of radiation dose and possible risks. Radiology (2004) 3.65
The phantom portion of the American College of Radiology (ACR) computed tomography (CT) accreditation program: practical tips, artifact examples, and pitfalls to avoid. Med Phys (2004) 3.27
Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. J Clin Endocrinol Metab (2002) 3.06
Trauma team oversight improves efficiency of care and augments clinical and economic outcomes. J Trauma (2008) 2.77
Curbing potential radiation-induced cancer risks in oncologic imaging: perspectives from the 'image gently' and 'image wisely' campaigns. Oncology (Williston Park) (2014) 2.76
Engaging our patients: shared decision making and interventional radiology. Radiology (2014) 2.53
Prospective evaluation of delayed technetium-99m sestamibi SPECT scintigraphy for preoperative localization of primary hyperparathyroidism. Surgery (2002) 2.18
Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism. Nat Genet (2013) 2.09
Informed Consent for Radiation Risk from CT Is Unjustified Based on the Current Scientific Evidence. Radiology (2015) 2.08
The operating room: war results in casualties. Anesth Analg (2003) 2.08
Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop. J Clin Endocrinol Metab (2014) 1.98
Radiation dose index of renal colic protocol CT studies in the United States: a report from the American College of Radiology National Radiology Data Registry. Radiology (2014) 1.93
Consensus statement on the terminology and classification of central neck dissection for thyroid cancer. Thyroid (2009) 1.90
The maturation of a specialty: Workforce projections for endocrine surgery. Surgery (2007) 1.80
Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. J Bone Miner Res (2002) 1.79
Computerized tomographic colonography: performance evaluation in a retrospective multicenter setting. Gastroenterology (2003) 1.73
One hundred laparoscopic adrenalectomies: a single surgeon's experience. Ann Surg Oncol (2003) 1.60
The effects of serum calcium and parathyroid hormone changes on psychological and cognitive function in patients undergoing parathyroidectomy for primary hyperparathyroidism. Ann Surg (2011) 1.55
Diagnostic radiography exposure increases the risk for thyroid microcarcinoma: a population-based case-control study. Eur J Cancer Prev (2015) 1.54
An "a la carte" academic radiology compensation plan: something for everyone. J Am Coll Radiol (2010) 1.52
Alterations of the SDHD gene locus in midgut carcinoids, Merkel cell carcinomas, pheochromocytomas, and abdominal paragangliomas. Genes Chromosomes Cancer (2002) 1.51
Hypercalcemia of malignancy due to ectopic transactivation of the parathyroid hormone gene. J Clin Endocrinol Metab (2005) 1.48
A survey of emergency physician-performed ultrasound: implications for academic radiology departments. J Am Coll Radiol (2011) 1.45
The Bethesda thyroid fine-needle aspiration classification system: year 1 at an academic institution. Thyroid (2009) 1.45
Hemorrhagic pheochromocytoma associated with systemic corticosteroid therapy and presenting as myocardial infarction with severe hypertension. J Clin Endocrinol Metab (2004) 1.40
Radiation dose associated with unenhanced CT for suspected renal colic: impact of repetitive studies. AJR Am J Roentgenol (2006) 1.39
American Thyroid Association design and feasibility of a prospective randomized controlled trial of prophylactic central lymph node dissection for papillary thyroid carcinoma. Thyroid (2012) 1.36
Early occurrence of RASSF1A hypermethylation and its mutual exclusion with BRAF mutation in thyroid tumorigenesis. Cancer Res (2004) 1.35
Stump appendicitis: a surgeon's dilemma. JSLS (2011) 1.32
Comprehensive re-sequencing of adrenal aldosterone producing lesions reveal three somatic mutations near the KCNJ5 potassium channel selectivity filter. PLoS One (2012) 1.30
Prognosis of primary thyroid lymphoma: demographic, clinical, and pathologic predictors of survival in 1,408 cases. Surgery (2009) 1.28
Spontaneous adrenal hemorrhage with associated masses: etiology and management in 6 cases and a review of 133 reported cases. World J Surg (2012) 1.26
Identification of somatic mutations in parathyroid tumors using whole-exome sequencing. J Clin Endocrinol Metab (2012) 1.26
25-hydroxyvitamin D(3)-1alpha-hydroxylase expression in normal and pathological parathyroid glands. J Clin Endocrinol Metab (2002) 1.24
Image Wisely: a campaign to increase awareness about adult radiation protection. Radiology (2010) 1.21
Methylation of the thyroid-stimulating hormone receptor gene in epithelial thyroid tumors: a marker of malignancy and a cause of gene silencing. Cancer Res (2003) 1.20
Controversy surrounding the role for routine central lymph node dissection for differentiated thyroid cancer. Curr Opin Oncol (2010) 1.19
Total thyroidectomy for differentiated thyroid cancer. J Surg Oncol (2006) 1.17
Traditional clinical risk assessment tools do not accurately predict coronary atherosclerotic plaque burden: a CT angiography study. AJR Am J Roentgenol (2009) 1.13
Size-specific dose estimation for CT: how should it be used and what does it mean? Radiology (2012) 1.13
Focused approach to parathyroidectomy. World J Surg (2008) 1.13
Detection of colorectal lesions: lower-dose multi-detector row helical CT colonography compared with conventional colonoscopy. Radiology (2003) 1.13
Response. Radiology (2015) 1.11
Gene expression profiling of benign and malignant pheochromocytoma. Ann N Y Acad Sci (2006) 1.08
Implementation of an international teleradiology staffing model. Radiology (2004) 1.08
Rehospitalization among elderly patients with thyroid cancer after thyroidectomy are prevalent and costly. Ann Surg Oncol (2010) 1.07
Familial parathyroid tumors: diagnosis and management. World J Surg (2009) 1.05
Thyroid follicular lesion of undetermined significance: Evaluation of the risk of malignancy using the two-tier sub-classification. Diagn Cytopathol (2011) 1.05
Guidelines for interactions between clinical faculty and the pharmaceutical industry: one medical school's approach. Acad Med (2006) 1.05
Adrenocortical Carcinoma: Current Therapeutic State-of-the-Art. J Oncol (2012) 1.05
Pediatric endocrine surgery: who is operating on our children? Surgery (2008) 1.04
Surveillance for early detection of aggressive parathyroid disease: carcinoma and atypical adenoma in familial isolated hyperparathyroidism associated with a germline HRPT2 mutation. J Bone Miner Res (2006) 1.01
4D parathyroid CT as the initial localization study for patients with de novo primary hyperparathyroidism. Ann Surg Oncol (2010) 1.00
Emergency radiology coverage: technical and clinical feasibility of an international teleradiology model. Emerg Radiol (2003) 1.00
Same-day thyroidectomy: a review of practice patterns and outcomes for 1,168 procedures in New York State. Ann Surg Oncol (2010) 1.00
Tall cell variant of papillary thyroid microcarcinoma: clinicopathologic features with BRAF(V600E) mutational analysis. Thyroid (2013) 0.99
Thyroid cancer. Annu Rev Med (2013) 0.98
The treatment of differentiated thyroid cancer in children: emphasis on surgical approach and radioactive iodine therapy. Endocr Rev (2011) 0.98
Parathyroidectomy improves neurocognitive deficits in patients with primary hyperparathyroidism. Surgery (2005) 0.95
Whole-exome sequencing characterizes the landscape of somatic mutations and copy number alterations in adrenocortical carcinoma. J Clin Endocrinol Metab (2014) 0.94
The activating TERT promoter mutation C228T is recurrent in subsets of adrenal tumors. Endocr Relat Cancer (2014) 0.94
BRAFV600E mutation in papillary thyroid microcarcinoma: a genotype-phenotype correlation. Mod Pathol (2012) 0.93
The risk of second cancers after diagnosis of primary thyroid cancer is elevated in thyroid microcarcinomas. Thyroid (2013) 0.93
Attrition of categoric general surgery residents: results of a 20-year audit. Am J Surg (2009) 0.93
Comprehensive DNA methylation analysis of benign and malignant adrenocortical tumors. Genes Chromosomes Cancer (2012) 0.93
Superiority of minimally invasive parathyroidectomy. Adv Surg (2012) 0.92
Molecular genetics of gastroenteropancreatic neuroendocrine tumors. Curr Opin Oncol (2009) 0.92
Evaluation of an emergency radiology quality assurance program at a level I trauma center: abdominal and pelvic CT studies. Radiology (2002) 0.92
Involvement of the MEN1 gene locus in familial isolated hyperparathyroidism. Eur J Endocrinol (2002) 0.91
Follicular neoplasms of the thyroid: what to recommend. Thyroid (2005) 0.91
Frequent germ-line mutations of the MEN1, CASR, and HRPT2/CDC73 genes in young patients with clinically non-familial primary hyperparathyroidism. Horm Cancer (2012) 0.91
First use of intravenous chemotherapy cancer treatment: rectifying the record. J Am Coll Surg (2011) 0.91
The DNA methylome of benign and malignant parathyroid tumors. Genes Chromosomes Cancer (2011) 0.90
CT colonography: multiobserver diagnostic performance. Radiology (2002) 0.90
Clinical review: Parathyroid localization and implications for clinical management. J Clin Endocrinol Metab (2013) 0.89
Insular variant of poorly differentiated thyroid carcinoma. Endocr Pract (2011) 0.89
Trans-oral Vestibular Endocrine Surgery: A New Technique in the United States. Ann Surg (2016) 0.88
Reflex BRAF testing in thyroid fine-needle aspiration biopsy with equivocal and positive interpretation: a prospective study. Thyroid (2011) 0.87
Loss of heterozygosity on the short arm of chromosome 1 in pheochromocytoma and abdominal paraganglioma. World J Surg (2002) 0.87
The tumor suppressor gene RIZ in cancer gene therapy (review). Oncol Rep (2001) 0.87
Surgery for primary hyperparathyroidism. Cancer (2014) 0.86
Autoimmune pancreatitis presenting as simultaneous masses in the pancreatic head and gallbladder. JOP (2005) 0.86
Vanishing thyroid tumors: a diagnostic dilemma after ultrasonography-guided fine-needle aspiration. Thyroid (2012) 0.86
Defining surgical therapy for pseudomembranous colitis with toxic megacolon. J Clin Gastroenterol (2008) 0.86
Minimally invasive parathyroidectomy. Surg Oncol (2003) 0.86